Market revenue in 2022 | USD 53.0 million |
Market revenue in 2030 | USD 89.4 million |
Growth rate | 6.8% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Reagents & Consumables |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.09% in 2022. Horizon Databook has segmented the Sweden thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The thrombosis and hemostasis biomarkers market in Sweden is growing primarily due to a surge in demand for diagnostics tests, which is driven by the increasing prevalence of chronic diseases. In addition, the country has advanced healthcare infrastructure, increasing awareness of point-of-care testing, and high disposable income.
Initiatives are being undertaken by private and public firms to invest in R&D. The country’s precision medicine industry has received significant investments over the recent past. For instance, in September 2021, Swedish national infrastructure Genomic Medicine Sweden (GMS) received USD 25.6 million in funding for the development of precision medicine therapeutics.
Such strategies are likely to boost the thrombosis and hemostasis biomarkers market. Some of the key players in the market are Siemens Healthineers, Abbott Laboratories, and Bio-Rad Laboratories.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Sweden thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account